SeaStar Medical Holding Corp

SeaStar Medical Holding Corp, trading under the ticker LMAO, is a blank-check company incorporated in the healthcare and medical-device sector that completed its IPO in 2021. The SPAC filed a Form 10-Q with the Securities and Exchange Commission on August 16, 2021, under accession number 0001564590-21-044716, reflecting its early post-IPO operating period as it pursued a target acquisition in the life-sciences space. SeaStar Medical, the operating company that ultimately combined with this vehicle, develops selective cytopheretic devices aimed at treating acute kidney injury in critically ill patients. The SPAC's distinctive ticker made it one of the more recognizable names on the market during the 2021 SPAC boom. Sign up for a full SpacDesk account to access complete filings, deal timelines, and sponsor data for LMAO and hundreds of other SPACs.